by Paul Pyzowski, Guest Contributor
I had recently written an article here on the use of MEMS in neuroscience research applications, and Colin Johnson penned a separate article on how MEMS are enabling systems to restore sight for the blind. This article focuses on the increasing use of MEMS for treating diseases and injuries of the central nervous system (brain and spine), including paralysis, Parkinson’s disease, and drug-resistant depression.
As background, according to Zack Lynch at the Neurotech Industry Organization, medical devices for treatment of nervous system disorders is a $7 billion market. Although small compared to the $120 billion market for neuropharmaceuticals, the neuro-device market is growing at 15% per year and is considered a real growth market, albeit one with considerable investment requirements and considerable risk.